About this trial
This study evaluates whether a home-based telerehabilitation program (tele-CPASS) is as effective as an in-person rehabilitation program (CPASS) for improving arm and hand function after stroke. Stroke often leads to long-term difficulty using the affected arm in daily activities, and access to in-person therapy can be limited. This study aims to determine whether therapy delivered remotely can provide similar benefits to standard in-clinic care.
Participants who recently experienced a stroke will be randomly assigned to receive 20 hours of upper extremity rehabilitation therapy either in person or through a telehealth platform. Both groups will receive the same type and amount of therapy focused on practicing meaningful, patient-selected daily activities. Participants will complete assessments before treatment, immediately after treatment, and at 6 and 12 months to measure recovery of arm function, real-world arm use, and participation in daily life.
The results of this study will help determine whether telerehabilitation can improve access to effective stroke recovery interventions while maintaining clinical effectiveness comparable to in-person therapy.
Eligibility criteria
Qualifiers
Age 21 years or older
Neuroimaging-confirmed stroke within 40 days prior to enrollment
Persistent hemiparesis resulting in impaired upper extremity function, defined by a score of 0 to 3 on the NIH Stroke Scale motor arm item
Able to participate in all study-related activities, including 1-year follow-up
Disqualifiers
Inability to provide informed consent
Persistent disabling neurologic condition, such as multiple sclerosis, Parkinsonism, amyotrophic lateral sclerosis, or dementia requiring medication
Clinically significant fluctuations in mental status within 72 hours prior to randomization
Active psychosis, psychosis within the prior 2 years, active substance abuse, or prior substance abuse
Trial design
Treatments tested in this trial
- Tele-CPASS
- In-person CPASS therapy
Treatment groups
Sponsors and collaborators
University of Texas, El Paso
Lead sponsor
Texas Tech University Health Sciences Center, El Paso
Collaborator
The Catholic University of America
Collaborator